By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ACADIA Pharmaceuticals, Inc. 

3911 Sorrento Valley Boulevard

San Diego  California  92121   U.S.A.
Phone: 858-558-2871 Fax: 858-558-2872


Drug Discovery


Allergan  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Allergan  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Allergan  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Sunovion Pharmaceuticals Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Company News
Acadia (ACAD) Reports Third Quarter 2015 Financial Results 11/6/2015 11:19:18 AM
Acadia (ACAD) To Present At The 24th Annual Credit Suisse Healthcare Conference On November 10, 2015 11/4/2015 11:21:29 AM
Acadia (ACAD) Announces FDA Priority Review Of NUPLAZID (Pimavanserin) New Drug Application For Parkinson’s Disease Psychosis 11/2/2015 10:09:19 AM
Acadia (ACAD) To Announce Third Quarter Financial Results On November 5, 2015 10/29/2015 11:34:57 AM
Acadia (ACAD) To Present At The Ladenburg Thalmann 2015 Healthcare Conference On September 29, 2015 9/23/2015 11:02:19 AM
Acadia (ACAD) Submits New Drug Application For NUPLAZID For The Treatment Of Parkinson’s Disease Psychosis 9/3/2015 10:52:06 AM
Acadia (ACAD) Appoints Steve Davis as CEO 9/3/2015 5:44:43 AM
Acadia (ACAD) Reports Second Quarter 2015 Financial Results 8/7/2015 8:04:03 AM
Acadia (ACAD) Announces Publication Of Data From Its -015 Open Label Safety Study In Parkinson’s Disease Psychosis In The Journal Of The American Medical Directors Association 8/6/2015 12:29:15 PM
Acadia (ACAD) Announces Senior Management Appointments In Manufacturing, Quality, Compliance, Access And Reimbursement And Business Development 8/5/2015 12:23:28 PM